April 1-3, 2025
Javits Center, NYC

2024 Call for Programming


The Technical Conference at INTERHEX features industry-current technical and scientific sessions lead by experts in inspection, formulation, cell & gene advancements, pharma 4.0, automation, and other areas challenging business today. The transformative program is designed to bridge the gap between science and business, giving attendees the expertise they need to enhance scalability and revenue generation.

The 2024 Call for Programming is now closed. If you have any questions, please reach out to Amar Batra at [email protected].

INTERPHEX is reinventing its education space with its 2024 Technical Conference. AAPS, INTERPHEX’S partner in developing the Technical Conference, has created the INTERPHEX Scientific Programming Advisory Committee (SPAC) to review and select the sessions for this year’s conference. 

Track 1: Non-Sterile Product Development and Manufacturing

Experts and innovators uncover the latest breakthroughs in non-sterile product development and manufacturing in three critical areas shaping the future of pharmaceuticals. Push the boundaries of science and technology that will shape the pharmaceutical industry's future!

Theme 1: Novel Pharmaceutical Materials and Processes
Keywords: Functional Excipients, Supply Chain, Drug Formulation, Long-acting Oral Delivery, Novel Drug Delivery, Packaging

Discover how technology is addressing stability challenges and eliminating cold-chain storage and distribution, as well as improving drug preservation and simplifying the supply chain. Explore the latest advances in functional excipients, unlocking new possibilities for drug formulation and delivery. Learn about the development of manufacturing and control strategies for complex polymer devices intended for long-acting oral delivery, paving the way for improved therapeutic outcomes. Look into the integration of novel excipients into non-sterile manufacturing processes and existing technologies, enhancing drug production efficiency. Explore new technology approaches to difficult dosage forms, such as liquid-filled gelatin capsules, with the potential for novel drug administration. Finally, uncover the transformative impact of packaging and storage technology advancements, ensuring the integrity and quality of pharmaceutical products.


Theme 2: Product Development and Manufacturing Challenges
Keywords: Continuous Processing and Manufacturing, 3D Printing, Compliance, Regulatory, PAT, QbD, Advanced Analytical Methods, On-demand Manufacturing

Explore the cutting edge of the field of product development and manufacturing and address the need for rapid response to supply chain challenges and global disruptions through innovative approaches such as on-demand manufacturing. Probe the compliance aspects of 3D printing approaches and continuous processing and manufacturing. Explore associated analytical and control approaches, including Process Analytical Technology (PAT) and Quality by Design (QbD), paving the way for improved production efficiency. Additionally, uncover new and advanced analytical approaches for characterization.

Theme 3. Pharma 4.0 and 5.0 – Implications of AI and Machine Learning Approaches
Keywords: AI/Machine Learning, Pharma 4.0/5.0, PAT, QbD

This theme explores advances and challenges in using artificial intelligence (AI) and machine learning (ML) in the pharmaceutical industry. Discuss the implementation of AI-based Process Analytical Technology (PAT) and predictive modeling in the development of drugs, highlighting their potential for improving efficiency and accuracy. Address the regulatory interface, emphasizing the role of AI in meeting the requirements and standards of Pharma 4.0/5.0. Focus on the critical aspects of data integrity, auditing, and compliance, both domestically and globally, ensuring transparency and accountability in using AI and ML in pharmaceutical processes.


Track 2: The Future is Now: Recent Advances in Sterile Product Manufacturing
The landscape of parental drug manufacturing is rapidly evolving, with the continuous emergence of new and more efficient technologies, as well as the advent of novel therapeutic modalities. Discuss novel, enabling, and diverse strategies to overcome current and emerging challenges in sterile product manufacturing.

Theme 1. Present and Future of Drug-Device Combination for Sterile Products
Keywords: Devices, Combination Products, Compliance, Sustainability, Lifecycle Management, Implantable Devices

Focus on the present and future of drug-device combination across all modalities for sterile products such as autoinjectors, connected and smart autoinjectors, both biodurable and bioerodible implantable devices (i.e., intraocular, subcutaneous, intrathecal, etc.), large-volume patch injectors, etc. Discuss the regulatory and compliance aspects, comparative analyses for generic combination products, industrial challenges, product sustainability, lifecycle management, and other technological advances.

Theme 2. Tackling the CMC Challenges of New Therapeutic Modalities
Keywords: New Therapeutic Modalities, Cell and Gene Therapy, Autologous Therapy, Cold Chain Management, Biologics

The curative potential of new therapeutic modalities (such as cell and gene therapy, nucleotide-based therapeutics, and in vivo expressed biologics) has led to an explosion of interest and investment in this space in the past five years. While parallels can be drawn with small molecule drugs and monoclonal antibodies, there are a number of unique and significant challenges for the manufacture of these novel therapeutics. Discuss topics such as new technologies to increase yields, reduce manufacturing costs, and shorten turnaround time, as well as chain of identity and chain of custody for autologous therapies, cold chain management, agile supply chains supporting a resilient ecosystem, accessibility of GMP-grade reagents, and regulatory/compliance expectations.

Theme 3. Current Trends in Parenteral Drug Manufacturing
Keywords: Process Development, Manufacturing Facility, Environmental Monitoring, Process Engineering, Novel Excipients, Lipid Nanoparticles, Supply Chain

Parenteral administration has enabled targeted drug delivery of complex molecules such as proteins and mRNA, as well as small molecules for treating various diseases that need site-specific targeting and to minimize side effects. Developmental considerations such as technologies involving upstream and downstream processes, development of novel delivery modalities like lipid nanoparticles, and designing well-controlled manufacturing facilities have progressed over the course of years to provide the best suited manufacturing processes for various injectable products. Supply chain management plays a pivotal role in ensuring product quality and viability. Discuss current trends in manufacturing parenteral drug products, innovative technologies for delivery systems, downstream processing technologies, and facility design considerations, along with trends and challenges faced by supply-chain management.


  • Submissions require a title, short description, 2-3 learning objectives, and proposed speakers that fit in a 30–45-minute session. The committee welcomes proposals for individual presentations, panels, and any other session structure that will help audiences engage with you.
  • Session ideas should align with the 2024 INTERPHEX Technical Conference themes .
  • Sessions must present research, scientific insights, best practices, or other non-commercial information. Session proposals that focus on a particular product or that attempt to market a company or its brand will be rejected.
  • Proposals will be reviewed by the SPAC for scientific credibility, industry relevance, and novelty. The status of proposals will be conveyed to all submitters in November 2023.

Please note: additional guidelines and step-by-step instructions will be provided throughout the submission process on the portal.